LewisCE, FineLJ, BeddhuS, CheungAK, CushmanWC, CutlerJA, et al.; SPRINT Research Group: Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med384: 1921–1930, 2021PubMed
LewisCE, FineLJ, BeddhuS, CheungAK, CushmanWC, CutlerJA, ; SPRINT Research Group: Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med 384: 1921–1930, 2021PubMed10.1056/NEJMoa1901281)| false
ThomopoulosC, ParatiG, ZanchettiA: Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13-benefits and adverse events in older and younger patients with hypertension: Overview, meta-analyses and meta-regression analyses of randomized trials. J Hypertens36: 1622–1636, 2018PubMed
ThomopoulosC, ParatiG, ZanchettiA: Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 13-benefits and adverse events in older and younger patients with hypertension: Overview, meta-analyses and meta-regression analyses of randomized trials. J Hypertens 36: 1622–1636, 2018PubMed10.1097/HJH.0000000000001787)| false
WheltonPK, CareyRM, AronowWS, CaseyDEJr, CollinsKJ, HimmelfarbCD, et al.: ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension71: 1269–1324, 2017
WheltonPK, CareyRM, AronowWS, CaseyDEJr, CollinsKJ, HimmelfarbCD, : ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension 71: 1269–1324, 2017)| false
ViraniSS, AlonsoA, AparicioHJ, BenjaminEJ, BittencourtMS, CallawayCW, et al.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2021 update: A report from the American Heart Association. Circulation143: e254–e743, 2021PubMed
ViraniSS, AlonsoA, AparicioHJ, BenjaminEJ, BittencourtMS, CallawayCW, ; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2021 update: A report from the American Heart Association. Circulation 143: e254–e743, 2021PubMed10.1161/CIR.0000000000000950)| false
MillsKT, BundyJD, KellyTN, ReedJE, KearneyPM, ReynoldsK, et al.: Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation134: 441–450, 2016PubMed
MillsKT, BundyJD, KellyTN, ReedJE, KearneyPM, ReynoldsK, : Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation 134: 441–450, 2016PubMed10.1161/CIRCULATIONAHA.115.018912)| false
NCD Risk Factor Collaboration (NCD-RisC): Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants [published correction appears in Lancet 399: 520, 2022]. Lancet398: 957–980, 2021PubMed
NCD Risk Factor Collaboration (NCD-RisC): Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants [published correction appears in Lancet 399: 520, 2022]. Lancet 398: 957–980, 2021PubMed10.1016/S0140-6736(21)01330-1)| false
ForouzanfarMH, LiuP, RothGA, NgM, BiryukovS, MarczakL, et al.: Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA317: 165–182, 2017PubMed
ForouzanfarMH, LiuP, RothGA, NgM, BiryukovS, MarczakL, : Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA 317: 165–182, 2017PubMed10.1001/jama.2016.19043)| false
MuntnerP, HardyST, FineLJ, JaegerBC, WozniakG, LevitanEB, et al.: Trends in blood pressure control among US adults with hypertension, 1999–2000 to 2017–2018. JAMA324: 1190–1200, 2020PubMed
MuntnerP, HardyST, FineLJ, JaegerBC, WozniakG, LevitanEB, : Trends in blood pressure control among US adults with hypertension, 1999–2000 to 2017–2018. JAMA 324: 1190–1200, 2020PubMed10.1001/jama.2020.14545)| false
JamesPA, OparilS, CarterBL, CushmanWC, Dennison-HimmelfarbC, HandlerJ, et al.: 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA311: 507–520, 2014PubMed
JamesPA, OparilS, CarterBL, CushmanWC, Dennison-HimmelfarbC, HandlerJ, : 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311: 507–520, 2014PubMed10.1001/jama.2013.284427)| false
World Health Organization. Guideline for the pharmacological treatment of hypertension in adults, Geneva, Switzerland, World Health Organization, 2021
13
SiuAL; US Preventive Services Task Force: Screening for high blood pressure in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med163: 778–786, 2015PubMed
SiuAL; US Preventive Services Task Force: Screening for high blood pressure in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med 163: 778–786, 2015PubMed10.7326/M15-2223)| false
KristAH, DavidsonKW, MangioneCM, CabanaM, CaugheyAB, DavisEM, et al.; US Preventive Services Task Force: Screening for hypertension in adults: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA325: 1650–1656, 2021PubMed
Guirguis-BlakeJM, EvansCV, WebberEM, CoppolaEL, PerdueLA, WeyrichMS: Screening for hypertension in adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA325: 1657–1669, 2021PubMed
Guirguis-BlakeJM, EvansCV, WebberEM, CoppolaEL, PerdueLA, WeyrichMS: Screening for hypertension in adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 325: 1657–1669, 2021PubMed10.1001/jama.2020.21669)| false
AbdallaM, MuntnerP, PetersonED: The USPSTF recommendation on blood pressure screening: Making 2021 the transformative year in controlling hypertension. JAMA325: 1618–1619, 2021PubMed
AbdallaM, MuntnerP, PetersonED: The USPSTF recommendation on blood pressure screening: Making 2021 the transformative year in controlling hypertension. JAMA 325: 1618–1619, 2021PubMed10.1001/jama.2021.4499)| false
AnsteyDE, BradleyC, ShimboD: USPSTF Recommendation Statement on Hypertension Screening in Adults-Where do we go from here?JAMA Netw Open4: e214203, 2021PubMed
AnsteyDE, BradleyC, ShimboD: USPSTF Recommendation Statement on Hypertension Screening in Adults-Where do we go from here?JAMA Netw Open 4: e214203, 2021PubMed10.1001/jamanetworkopen.2021.4203)| false
FerdinandKC, BrownAL: Will the 2021 USPSTF hypertension screening recommendation decrease or worsen racial/ethnic disparities in blood pressure control?JAMA Netw Open 4: e213718, 2021PubMed10.1001/jamanetworkopen.2021.3718)| false
YanoY, Lloyd-JonesDM: USPSTF Recommendations for Screening for Hypertension in Adults: It is time to unmask hypertensive risk. JAMA Cardiol6: 869–871, 2021PubMed
YanoY, Lloyd-JonesDM: USPSTF Recommendations for Screening for Hypertension in Adults: It is time to unmask hypertensive risk. JAMA Cardiol 6: 869–871, 2021PubMed10.1001/jamacardio.2021.1122)| false
YangWY, MelgarejoJD, ThijsL, ZhangZY, BoggiaJ, WeiFF, et al.; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators: Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes. JAMA322: 409–420, 2019PubMed
YangWY, MelgarejoJD, ThijsL, ZhangZY, BoggiaJ, WeiFF, ; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators: Association of office and ambulatory blood pressure with mortality and cardiovascular outcomes. JAMA 322: 409–420, 2019PubMed10.1001/jama.2019.9811)| false
Blood Pressure Lowering Treatment Trialists’ Collaboration: Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: An individual participant-level data meta-analysis. Lancet397: 1625–1636, 2021PubMed
Blood Pressure Lowering Treatment Trialists’ Collaboration: Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: An individual participant-level data meta-analysis. Lancet 397: 1625–1636, 2021PubMed10.1016/S0140-6736(21)00590-0)| false
FontilV, PaccaL, BellowsBK, KhoongE, McCullochCE, PletcherM, et al.: Association of differences in treatment intensification, missed visits, and scheduled follow-up interval with racial or ethnic disparities in blood pressure control. JAMA Cardiol7: 204–212, 2022PubMed
FontilV, PaccaL, BellowsBK, KhoongE, McCullochCE, PletcherM, : Association of differences in treatment intensification, missed visits, and scheduled follow-up interval with racial or ethnic disparities in blood pressure control. JAMA Cardiol 7: 204–212, 2022PubMed10.1001/jamacardio.2021.4996)| false
Commodore-MensahY, Dennison HimmelfarbC: Treatment intensification and missed visits as important targets for reducing racial and ethnic disparities in hypertension control. JAMA Cardiol7: 213–214, 2021
Commodore-MensahY, Dennison HimmelfarbC: Treatment intensification and missed visits as important targets for reducing racial and ethnic disparities in hypertension control. JAMA Cardiol 7: 213–214, 202110.1001/jamacardio.2021.5003)| false
GuA, YueY, DesaiRP, ArgulianE: Racial and ethnic differences in antihypertensive medication use and blood pressure control among US adults with hypertension: The National Health and Nutrition Examination Survey, 2003 to 2012. Circ Cardiovasc Qual Outcomes10: e003166, 2017PubMed
GuA, YueY, DesaiRP, ArgulianE: Racial and ethnic differences in antihypertensive medication use and blood pressure control among US adults with hypertension: The National Health and Nutrition Examination Survey, 2003 to 2012. Circ Cardiovasc Qual Outcomes 10: e003166, 2017PubMed10.1161/CIRCOUTCOMES.116.003166)| false
PajewskiNM, BerlowitzDR, BressAP, CallahanKE, CheungAK, FineLJ, et al.: Intensive vs standard blood pressure control in adults 80 years or older: A secondary analysis of the systolic blood pressure intervention trial. J Am Geriatr Soc68: 496–504, 2020PubMed
PajewskiNM, BerlowitzDR, BressAP, CallahanKE, CheungAK, FineLJ, : Intensive vs standard blood pressure control in adults 80 years or older: A secondary analysis of the systolic blood pressure intervention trial. J Am Geriatr Soc 68: 496–504, 2020PubMed10.1111/jgs.16272)| false
D’AnciKE, TiptonK, Hedden-GrossA, RouseB, HermansonL, FontanarosaJ: Effect of intensive blood pressure lowering on cardiovascular outcomes: A systematic review prepared for the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Guidelines. Ann Intern Med173: 895–903, 2020PubMed
D’AnciKE, TiptonK, Hedden-GrossA, RouseB, HermansonL, FontanarosaJ: Effect of intensive blood pressure lowering on cardiovascular outcomes: A systematic review prepared for the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Guidelines. Ann Intern Med 173: 895–903, 2020PubMed10.7326/M20-2037)| false
FlynnJT, KaelberDC, Baker-SmithCM, BloweyD, CarrollAE, DanielsSR, et al.; Subcommittee on Screening and Management of High Blood Pressure in Children: Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics140: e20171904, 2017PubMed
FlynnJT, KaelberDC, Baker-SmithCM, BloweyD, CarrollAE, DanielsSR, ; Subcommittee on Screening and Management of High Blood Pressure in Children: Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics 140: e20171904, 2017PubMed10.1542/peds.2017-1904)| false
HintonTC, AdamsZH, BakerRP, HopeKA, PatonJFR, HartEC, et al.: Investigation and treatment of high blood pressure in young people: Too much medicine or appropriate risk reduction?Hypertension75: 16–22, 2020PubMed
HintonTC, AdamsZH, BakerRP, HopeKA, PatonJFR, HartEC, : Investigation and treatment of high blood pressure in young people: Too much medicine or appropriate risk reduction?Hypertension 75: 16–22, 2020PubMed10.1161/HYPERTENSIONAHA.119.13820)| false
LeeH, YanoY, ChoSMJ, ParkJH, ParkS, Lloyd-JonesDM, et al.: Cardiovascular risk of isolated systolic or diastolic hypertension in young adults. Circulation141: 1778–1786, 2020PubMed
JonesDW, WheltonPK, AllenN, Clark3rdD, GiddingSS, MuntnerP, et al.; American Heart Association Council on Hypertension; Council on the Kidney in Cardiovascular Disease; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; and Stroke Council: Management of stage 1 hypertension in adults with a low 10-year risk for cardiovascular disease: Filling a guidance gap: A scientific statement from the American Heart Association. Hypertension77: e58–e67, 2021PubMed
JonesDW, WheltonPK, AllenN, Clark3rdD, GiddingSS, MuntnerP, ; American Heart Association Council on Hypertension; Council on the Kidney in Cardiovascular Disease; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; and Stroke Council: Management of stage 1 hypertension in adults with a low 10-year risk for cardiovascular disease: Filling a guidance gap: A scientific statement from the American Heart Association. Hypertension 77: e58–e67, 2021PubMed10.1161/HYP.0000000000000195)| false
American Diabetes Association Professional Practice Committee: 10. Cardiovascular disease and risk management: Standards of medical care in diabetes-2022. Diabetes Care45: S144–S174, 2022PubMed
American Diabetes Association Professional Practice Committee: 10. Cardiovascular disease and risk management: Standards of medical care in diabetes-2022. Diabetes Care 45: S144–S174, 2022PubMed10.2337/dc22-S010)| false
Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group: KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int99: S1–S87, 2021PubMed
Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group: KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int 99: S1–S87, 2021PubMed10.1016/j.kint.2020.11.003)| false
RoereckeM, KaczorowskiJ, MyersMG: Comparing automated office blood pressure readings with other methods of blood pressure measurement for identifying patients with possible hypertension: A systematic review and meta-analysis. JAMA Intern Med179: 351–362, 2019PubMed
RoereckeM, KaczorowskiJ, MyersMG: Comparing automated office blood pressure readings with other methods of blood pressure measurement for identifying patients with possible hypertension: A systematic review and meta-analysis. JAMA Intern Med 179: 351–362, 2019PubMed10.1001/jamainternmed.2018.6551)| false
CheungAK, RahmanM, ReboussinDM, CravenTE, GreeneT, KimmelPL, et al.; SPRINT Research Group: Effects of intensive BP control in CKD. J Am Soc Nephrol28: 2812–2823, 2017PubMed
CheungAK, RahmanM, ReboussinDM, CravenTE, GreeneT, KimmelPL, ; SPRINT Research Group: Effects of intensive BP control in CKD. J Am Soc Nephrol 28: 2812–2823, 2017PubMed10.1681/ASN.2017020148)| false
